| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Ozden Rabia Gurses is a Chief Medical Officer at OCULAR THERAPEUTIX, INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | OCUL Ocular Therapeutix, Inc | Chief Medical Officer | Sell | 6,346 | $4.86 | $30,841.56 | -4.0% | +17.2% | +58.0% | |
| Jan 31, 2024 | OCUL Ocular Therapeutix, Inc | Chief Medical Officer | Sell | 7,764 | $4.95 | $38,431.80 | -7.7% | -2.5% | +60.1% | |
| Jul 7, 2023 | OCUL Ocular Therapeutix, Inc | Chief Medical Officer | Sell | 832 | $4.93 | $4,101.76 | -0.8% | -39.1% | +36.4% | |
| Feb 6, 2023 | OCUL Ocular Therapeutix, Inc | Chief Medical Officer | Sell | 6,416 | $4.24 | $27,203.84 | -6.0% | +50.6% | +18.6% |